Effect of Peppermint on nausea, vomiting and anorexia in patients with breast cancer under chemotherapy

Comparative effect of Peppermint (Mentha Piperita) with placebo on nausea, vomiting and anorexia in patients with breast cancer under chemotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20130731014229N7

Enrollment

Registered

2018-04-19

Start date

2018-05-22

Completion date

Unknown

Last updated

2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nausea and vomiting. Nausea and vomiting

Interventions

Intervention 1: In the intervention group, in addition to the medications prescribed by the physician, will be given 40 drops of peppermint of Barij Essence Company plus 20 cc of water every 8 hours,

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Satisfaction to participate in the study Diagnosis of breast cancer History of receiving a chemotherapy course Experience nausea following previous chemotherapy

Exclusion criteria

Exclusion criteria: Unwillingness to continue participating in the study Forgetting the use of Peppermint in three times

Design outcomes

Primary

Measure	Time frame
Nausea. Timepoint: At the beginning of the study (before the intervention) and immediately, 24 and 48 hours after the end of the chemotherapy. Method of measurement: VAS scale.;Vomiting. Timepoint: At the beginning of the study (before the intervention) and immediately, 24 and 48 hours after the end of the chemotherapy. Method of measurement: Frequency table.;Anorexia. Timepoint: At the beginning of the study (before the intervention) and immediately, 24 and 48 hours after the end of the chemotherapy. Method of measurement: VAS Scale.	—

Measure

Time frame

Nausea. Timepoint: At the beginning of the study (before the intervention) and immediately, 24 and 48 hours after the end of the chemotherapy. Method of measurement: VAS scale.;Vomiting. Timepoint: At the beginning of the study (before the intervention) and immediately, 24 and 48 hours after the end of the chemotherapy. Method of measurement: Frequency table.;Anorexia. Timepoint: At the beginning of the study (before the intervention) and immediately, 24 and 48 hours after the end of the chemotherapy. Method of measurement: VAS Scale.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHadi Jafarimanesh

Arak University of Medical Sciences

nurse_science@yahoo.com+98 86 3417 3503

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026